Q4 Financial Statement: Talis Biomedical Corp. (TLIS) Stock Plunged Deep in Early Trades.
Talis Biomedical Corp. (TLIS) delivers precise infectious disease testing as it is devoted to progressing health equity and outcomes. The company plans the production and